clinical trial · NCT07372924
A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)
Jiangsu HengRui Medicine Co., Ltd.·phase2·recruiting·n = 120
Abirritation in the ICUTegileridine Fumarate lnjectionTegileridine Fumarate lnjectionRemifentanil Hydrochloride for Injection
brief summary
The purpose of this study is to evaluate the efficacy and safety of Tegileridine Fumarate lnjection for prolonged abirritation(48h to 72h) during mechanical ventilation in the ICU.
started
Feb 24, 2026
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Mar 13, 2026
official title
A Phase II, Multicenter, Randomized, Single-Blind, Dose Exploration, Positive Comparator Study to Evaluate the Efficacy and Safety of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol